Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on April 3, 2003

Stroke. 2003
Published online before print April 3, 2003, doi: 10.1161/01.STR.0000068782.15297.28
A more recent version of this article appeared on May 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/1224    most recent
01.STR.0000068782.15297.28v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wechsler, L. R.
Right arrow Articles by for the PROACT II Investigators
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wechsler, L. R.
Right arrow Articles by for the PROACT II Investigators,
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Fibrinolysis
Right arrow Emergency treatment of Stroke
Right arrow Thrombolysis

Submitted on November 18, 2002
Accepted on December 10, 2002

Factors Influencing Outcome and Treatment Effect in PROACT II

Lawrence R. Wechsler MD*; Robin Roberts MTech; Anthony J. Furlan MD; Randall T. Higashida MD; William Dillon MD; Heidi Roberts MD; Howard A. Rowley MD; L. Creed Pettigrew MD; Alfred S. Callahan III MD; Askiel Bruno MD; Pierre Fayad MD; Wade S. Smith MD; Carolyn M. Firszt MS; Gregory A. Schulz MS; and for the PROACT II Investigators

From the University of Pittsburgh (L.R.W.), Pittsburgh, Pa; McMaster University (R.R.), Hamilton, Canada; the Cleveland Clinic Foundation (A.J.F.), Cleveland, Ohio; the University of California (R.T.H., W.D., W.S.S.), San Francisco; the University of Toronto (H. Roberts), Toronto, Canada; the University of Wisconsin (H.A. Rowley), Madison; the University of Kentucky (L.C.P.), Lexington; the Centennial Medical Center (A.S.C. III), Nashville, Tenn; Indiana University (A.B.), Indianapolis, Ind; the University of Nebraska Medical Center (P.F.), Omaha; and Abbott Laboratories (C.M.F., G.A.S.), Abbott Park, Ill.

* To whom correspondence should be addressed. E-mail: lwechsler{at}stroke.upmc.edu.

Background and Purpose--The PROACT II study demonstrated a significant benefit from treatment with intra-arterial pro-urokinase (r-proUK) in patients with middle cerebral artery occlusion treated within 6 hours of stroke onset. The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment.

Methods--We selected from the baseline clinical, radiologic, and angiographic data variables that considered possibly related to outcome. A univariate analysis was performed to examine the association between these baseline factors and good outcome, defined as a modified Rankin scale score <=2. A multivariate model then selected the most important variables independently influencing prognosis. A risk score for each patient was constructed on the basis of the patient's individual values for each independent variable. Patients were stratified into risk quartiles based on their risk scores, and an odds ratio for each risk quartile was calculated. The treatment effects of each quartile were compared.

Results--In the univariate analysis, screening National Institutes of Health stroke scale (NIHSS) score and age were strongly associated with good outcome. The multivariate model selected age, NIHSS score, and CT hypodensity as the most important prognostic variables. Dividing patients into quartiles based on risk scores achieved a uniform gradient of probability of good outcomes. A trend toward benefit of r-proUK treatment was seen in all risk quartiles, and no differential treatment effect was observed across risk groups.

Conclusions--There was no evidence of differential effect of r-proUK across subgroups of patients stratified by risk.


Key words: outcome • stroke, acute • thrombolytic therapy




This article has been cited by other articles:


Home page
StrokeHome page
R. G. Nogueira, D. S. Liebeskind, G. Sung, G. Duckwiler, W. S. Smith, and on Behalf of the MERCI; and Multi MERCI Writing Co
Predictors of Good Clinical Outcomes, Mortality, and Successful Revascularization in Patients With Acute Ischemic Stroke Undergoing Thrombectomy: Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials
Stroke, December 1, 2009; 40(12): 3777 - 3783.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Khatri, T. Abruzzo, S. D. Yeatts, C. Nichols, J. P. Broderick, T. A. Tomsick, and For the IMS I and II Investigators
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent
Neurology, September 29, 2009; 73(13): 1066 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
R.G. Nogueira, A.J. Yoo, F.S. Buonanno, and J.A. Hirsch
Endovascular Approaches to Acute Stroke, Part 2: A Comprehensive Review of Studies and Trials
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 859 - 875.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Hallevi, A. D. Barreto, D. S. Liebeskind, M. M. Morales, S. B. Martin-Schild, A. T. Abraham, J. Gadia, J. L. Saver, the UCLA Intra-Arterial Therapy Investigators, J. C. Grotta, et al.
Identifying Patients at High Risk for Poor Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke, May 1, 2009; 40(5): 1780 - 1785.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. D. Barreto, K. C. Albright, H. Hallevi, J. C. Grotta, E. A. Noser, A. M. Khaja, H. M. Shaltoni, N. R. Gonzales, K. Illoh, S. Martin-Schild, et al.
Thrombus Burden Is Associated With Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke, December 1, 2008; 39(12): 3231 - 3235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E.S. Rosenthal, L.H. Schwamm, L. Roccatagliata, S.B. Coutts, A.M. Demchuk, P.W. Schaefer, R.G. Gonzalez, M.D. Hill, E.F. Halpern, and M.H. Lev
Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model
AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1471 - 1475.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Mattle, M. Arnold, D. Georgiadis, C. Baumann, K. Nedeltchev, D. Benninger, L. Remonda, C. von Budingen, A. Diana, A. Pangalu, et al.
Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign
Stroke, February 1, 2008; 39(2): 379 - 383.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. H. Shah, D. S. Liebeskind, J. L. Saver, S. Starkman, F. Vinuela, G. Duckwiler, R. Jahan, D. Kim, N. Sanossian, P. Vespa, et al.
Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke
Neurology, June 13, 2006; 66(11): 1745 - 1746.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
The IMS Study Investigators
Hemorrhage in the Interventional Management of Stroke Study
Stroke, March 1, 2006; 37(3): 847 - 851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
L. H. Schwamm, E. S. Rosenthal, C. J. Swap, J. Rosand, G. Rordorf, F. S. Buonanno, M. G. Vangel, W. J. Koroshetz, and M. H. Lev
Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome after Intra-Arterial Reperfusion Therapy
AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1798 - 1803.
[Abstract] [Full Text] [PDF]